Organization Overview
Timeline
Active Ingredients
Indications
Clinical Trials
Targets and Mechanisms
cerebrolysin (1 trial)
cenegermin-bkbj (oxervate) (1 trial)
emicholine (1 trial)
l-alpha-glycerophosphocholine (1 trial)
sargramostim (leukine) (1 trial)
Cerebral Infarction (Phase 4)
Ischemia (Phase 4)
Stroke (Phase 4)
Trials (3 total)
Trial APIs (5 total)